183 related articles for article (PubMed ID: 25985625)
1. [Metabolism enzyme controls cancer stemness].
Konno M; Doki Y; Mori M; Ishii H
Nihon Rinsho; 2015 May; 73(5):745-50. PubMed ID: 25985625
[TBL] [Abstract][Full Text] [Related]
2. [Novel mechanism for invasion and metastasis involving metabolic enzymes in intractable cancer cells].
Konno M; Hamabe A; Doki Y; Mori M; Ishii H
Rinsho Ketsueki; 2015 Aug; 56(8):1059-63. PubMed ID: 26345567
[TBL] [Abstract][Full Text] [Related]
3. Leptin promotes epithelial-mesenchymal transition of breast cancer via the upregulation of pyruvate kinase M2.
Wei L; Li K; Pang X; Guo B; Su M; Huang Y; Wang N; Ji F; Zhong C; Yang J; Zhang Z; Jiang Y; Liu Y; Chen T
J Exp Clin Cancer Res; 2016 Oct; 35(1):166. PubMed ID: 27769315
[TBL] [Abstract][Full Text] [Related]
4. Aspirin-triggered resolvin D1 inhibits TGF-β1-induced EMT through the inhibition of the mTOR pathway by reducing the expression of PKM2 and is closely linked to oxidative stress.
Liu Y; Yuan X; Li W; Cao Q; Shu Y
Int J Mol Med; 2016 Oct; 38(4):1235-42. PubMed ID: 27573422
[TBL] [Abstract][Full Text] [Related]
5. Pyruvate Kinase M2 Knockdown Suppresses Migration, Invasion, and Epithelial-Mesenchymal Transition of Gastric Carcinoma via Hypoxia-Inducible Factor Alpha/B-Cell Lymphoma 6 Pathway.
Li N; Meng D; Xu Y; Gao L; Shen F; Tie X; Zhang Y; Yi Z; Shen W; Liu Z; Xu Z
Biomed Res Int; 2020; 2020():7467104. PubMed ID: 33376737
[TBL] [Abstract][Full Text] [Related]
6. Pyruvate Kinase M2 Modulates Esophageal Squamous Cell Carcinoma Chemotherapy Response by Regulating the Pentose Phosphate Pathway.
Fukuda S; Miyata H; Miyazaki Y; Makino T; Takahashi T; Kurokawa Y; Yamasaki M; Nakajima K; Takiguchi S; Mori M; Doki Y
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1461-8. PubMed ID: 25808097
[TBL] [Abstract][Full Text] [Related]
7. Rocking cell metabolism: revised functions of the key glycolytic regulator PKM2 in cancer.
Chaneton B; Gottlieb E
Trends Biochem Sci; 2012 Aug; 37(8):309-16. PubMed ID: 22626471
[TBL] [Abstract][Full Text] [Related]
8. PKM2 contributes to cancer metabolism.
Wong N; Ojo D; Yan J; Tang D
Cancer Lett; 2015 Jan; 356(2 Pt A):184-91. PubMed ID: 24508027
[TBL] [Abstract][Full Text] [Related]
9. Nuclear EGFR-PKM2 axis induces cancer stem cell-like characteristics in irradiation-resistant cells.
Shi Y; Liu N; Lai W; Yan B; Chen L; Liu S; Liu S; Wang X; Xiao D; Liu X; Mao C; Jiang Y; Jia J; Liu Y; Yang R; Cao Y; Tao Y
Cancer Lett; 2018 May; 422():81-93. PubMed ID: 29477380
[TBL] [Abstract][Full Text] [Related]
10. Role of pyruvate kinase M2 in transcriptional regulation leading to epithelial-mesenchymal transition.
Hamabe A; Konno M; Tanuma N; Shima H; Tsunekuni K; Kawamoto K; Nishida N; Koseki J; Mimori K; Gotoh N; Yamamoto H; Doki Y; Mori M; Ishii H
Proc Natl Acad Sci U S A; 2014 Oct; 111(43):15526-31. PubMed ID: 25313085
[TBL] [Abstract][Full Text] [Related]
11. Changes in PKM2 associate with prostate cancer progression.
Wong N; Yan J; Ojo D; De Melo J; Cutz JC; Tang D
Cancer Invest; 2014 Aug; 32(7):330-8. PubMed ID: 24884829
[TBL] [Abstract][Full Text] [Related]
12. Activators of PKM2 in cancer metabolism.
Warner SL; Carpenter KJ; Bearss DJ
Future Med Chem; 2014 Jun; 6(10):1167-78. PubMed ID: 25078136
[TBL] [Abstract][Full Text] [Related]
13. The responsively decreased PKM2 facilitates the survival of pancreatic cancer cells in hypoglucose.
Li X; Deng S; Liu M; Jin Y; Zhu S; Deng S; Chen J; He C; Qin Q; Wang C; Zhao G
Cell Death Dis; 2018 Jan; 9(2):133. PubMed ID: 29374159
[TBL] [Abstract][Full Text] [Related]
14. PKM2 Promotes Breast Cancer Progression by Regulating Epithelial Mesenchymal Transition.
Xiao H; Zhang L; Chen Y; Zhou C; Wang X; Wang D; Liu Z
Anal Cell Pathol (Amst); 2020; 2020():8396023. PubMed ID: 33294309
[TBL] [Abstract][Full Text] [Related]
15. Pyruvate kinase M2: A multifarious enzyme in non-canonical localization to promote cancer progression.
Amin S; Yang P; Li Z
Biochim Biophys Acta Rev Cancer; 2019 Apr; 1871(2):331-341. PubMed ID: 30826427
[TBL] [Abstract][Full Text] [Related]
16. Nuclear PKM2 promotes the progression of oral squamous cell carcinoma by inducing EMT and post-translationally repressing TGIF2.
Tanaka F; Yoshimoto S; Okamura K; Ikebe T; Hashimoto S
Oncotarget; 2018 Sep; 9(73):33745-33761. PubMed ID: 30333907
[TBL] [Abstract][Full Text] [Related]
17. Targeting stromal-induced pyruvate kinase M2 nuclear translocation impairs oxphos and prostate cancer metastatic spread.
Giannoni E; Taddei ML; Morandi A; Comito G; Calvani M; Bianchini F; Richichi B; Raugei G; Wong N; Tang D; Chiarugi P
Oncotarget; 2015 Sep; 6(27):24061-74. PubMed ID: 26183399
[TBL] [Abstract][Full Text] [Related]
18. Nuclear translocation of PKM2/AMPK complex sustains cancer stem cell populations under glucose restriction stress.
Yang YC; Chien MH; Liu HY; Chang YC; Chen CK; Lee WJ; Kuo TC; Hsiao M; Hua KT; Cheng TY
Cancer Lett; 2018 May; 421():28-40. PubMed ID: 29408265
[TBL] [Abstract][Full Text] [Related]
19. Pyruvate kinase M2: A simple molecule with complex functions.
Alquraishi M; Puckett DL; Alani DS; Humidat AS; Frankel VD; Donohoe DR; Whelan J; Bettaieb A
Free Radic Biol Med; 2019 Nov; 143():176-192. PubMed ID: 31401304
[TBL] [Abstract][Full Text] [Related]
20. PKM2, a potential target for regulating cancer.
Li YH; Li XF; Liu JT; Wang H; Fan LL; Li J; Sun GP
Gene; 2018 Aug; 668():48-53. PubMed ID: 29775756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
